✦ LIBER ✦

Efficacy of natalizumab in multiple sclerosis patients with high disease activity: a Danish nationwide study

✍ Scribed by A. B. Oturai; N. Koch-Henriksen; T. Petersen; P. E. H. Jensen; F. Sellebjerg; P. S. Sorensen

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Predictors of freedom from disease activ

✍ Luca Prosperini; Costanza Giannì; Valeria Barletta; Chiara Mancinelli; Federica 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 732 KB

Effect of natalizumab on clinical and ra

✍ Eva Havrdova; Steven Galetta; Michael Hutchinson; Dusan Stefoski; David Bates; C 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 170 KB

Efficacy and tolerability of natalizumab

✍ F. Sangalli; L. Moiola; S. Bucello; P. Annovazzi; A. Rizzo; M. Radaelli; G. Vite 📂 Article 📅 2010 🏛 Springer Milan 🌐 English ⚖ 238 KB

The efficacy of natalizumab in patients

✍ M. Hutchinson; L. Kappos; P. A. Calabresi; C. Confavreux; G. Giovannoni; S. L. G 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 356 KB

The efficacy of natalizumab in patients

✍ Michael Hutchinson; Ludwig Kappos; Peter A. Calabresi; Christian Confavreux; Gav 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 170 KB

Effect of natalizumab on clinical and ra

✍ Melin, A.; Outteryck, O.; Collongues, N.; Zéphir, H.; Fleury, M. C.; Blanc, F.; 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 305 KB